The US Ambassador to India, Sergio Gor, mentioned that the United States relies on India for nearly 40% of its generic medicines due to the trust in India’s pharmaceutical capabilities. He highlighted the deepening ties between the two countries across various sectors such as trade, defense, technology, health, and space cooperation. Gor emphasized the critical role India plays in providing life-saving pharmaceutical ingredients to the United States.
Bilateral trade between India and the US has significantly increased over the past two decades, growing from 20 billion dollars to over 220 billion dollars in goods and services. Gor expressed optimism about the ongoing negotiations for an interim trade agreement between the two nations, expecting it to be finalized soon. He described the India-US relationship as one of the key partnerships of the 21st century.
Gor also noted the substantial investments by major US technology companies in India. Amazon is set to invest 35 billion dollars by 2030 to support digitization, exports, and job creation through AI-driven initiatives. Microsoft has announced a 17.5 billion dollar investment in India, focusing on expanding cloud infrastructure, while Google has initiated a project for a subsea cable landing terminal valued at around 15 billion dollars. These investments showcase the growing confidence of American companies in India as a safe and lucrative investment destination.
